HIT-SKK2000: BEHAVIORAL AND FUNCTIONAL PROBLEMS OF YOUNG CHILDREN WITH MEDULLOBLASTOMA AND EPENDYMOMA 5 YEARS AFTER DIAGNOSIS

被引：0
|
作者：
Frahsek, S. [1 ]
Rutkowski, S. [2 ]
Faldum, A. [3 ]
Ottensmeier, H. [1 ]
机构：
[1] Univ Childrens Hosp, Wurzburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[3] Univ Med Ctr Mainz, Inst Med Biostatist Epidemiol & Informat, Mainz, Germany
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：II76 / II76
页数：1
相关论文
共 10 条
  • [1] LONG TERM NEUROPSYCHOLOGICAL FOLLOW UP OF YOUNG CHILDREN WITH MEDULLOBLASTOMA AND EPENDYMOMA TREATED IN THE TRIALS HIT-SKK'87/'92 AND HIT 2000
    Ottensmeier, H.
    Frahsek, S.
    Faldum, A.
    Rutkowski, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II13 - II13
  • [2] Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment
    Ottensmeier, Holger
    Schlegel, Paul G.
    Eyrich, Matthias
    Wolff, Johannes E.
    Juhnke, Bjorn-Ole
    von Hoff, Katja
    Frahsek, Stefanie
    Schmidt, Rene
    Faldum, Andreas
    Fleischhack, Gudrun
    von Bueren, Andre
    Friedrich, Carsten
    Resch, Anika
    Warmuth-Metz, Monika
    Krauss, Juergen
    Kortmann, Rolf D.
    Bode, Udo
    Kuehl, Joachim
    Rutkowski, Stefan
    PLOS ONE, 2020, 15 (01):
  • [3] OUTCOME IN CHILDREN UNDER 3 YEARS OLD WITH MEDULLOBLASTOMA (MB) TREATED ACCORDING TO THE PROTOCOL HIT SKK 92/2000
    Geludkoya, Olga
    Kumirova, Ella
    Borodina, Irena
    Melikyan, Armen
    Kushel, Ury
    Shishkina, Ludmila
    Popov, Vladimir
    Livshits, Matvey
    Gorbatih, Svetlana
    Kholodov, Boris
    Scherbenko, Oleg
    Maksimova, Nina
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 747 - 748
  • [4] Neuropsychological Outcome of Different Treatments for Young Children with Medulloblastoma, Ependymoma and PNET: Multicenter Trial HIT 2000
    Ottensmeier, H.
    Schlegel, P. G.
    Wolff, J. E.
    Eyrich, M.
    Juhnke, B. O.
    von Hoff, K.
    Frahsek, S.
    Fleischhack, G.
    von Bueren, A.
    Friedrich, C.
    Mynarek, M.
    Resch, A.
    Warmuth-Metz, M.
    Krauss, J.
    Kortmann, R. D.
    Bode, U.
    Kuehl, J.
    Rutkowski, S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S427 - S427
  • [5] Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol
    Merlin, Marie-Sophie
    Schmitt, Emmanuelle
    Mezloy-Destracque, Malika
    Dufour, Christelle
    Riffaud, Laurent
    Puiseux, Chloe
    De Carli, Emilie
    Bodet, Damien
    Icher, Celine
    Doz, Francois
    Faure-Conter, Cecile
    Pagnier, Anne
    Pluchart, Claire
    Thouvenin-Doulet, Sandrine
    Lejeune, Julien
    Nguyen Thi, Phi-Linh
    Chastagner, Pascal
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (01) : 195 - 205
  • [6] Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol
    Marie-Sophie Merlin
    Emmanuelle Schmitt
    Malika Mezloy-Destracque
    Christelle Dufour
    Laurent Riffaud
    Chloé Puiseux
    Emilie De Carli
    Damien Bodet
    Céline Icher
    François Doz
    Cécile Faure-Conter
    Anne Pagnier
    Claire Pluchart
    Sandrine Thouvenin-Doulet
    Julien Lejeune
    Phi-Linh Nguyen Thi
    Pascal Chastagner
    Journal of Neuro-Oncology, 2023, 163 : 195 - 205
  • [7] NEUROCOGNITIVE AND RADIOLOGICAL FOLLOW-UP OF CHILDREN UNDER 5 YEARS OF AGE TREATED FOR MEDULLOBLASTOMA ACCORDING TO THE HIT-SKK PROTOCOL
    Merlin, Marie-Sophie
    Schmitt, Emmanuelle
    Mezloy-Destracque, Malika
    Dufour, Christelle
    Riffaud, Laurent
    Puiseux, Chloe
    De Carli, Emilie
    Bodet, Damien
    Icher, Celine
    Doz, Francois
    Faure-Conter, Cecile
    Pagnier, Anne
    Pluchart, Claire
    Thouvenin-Doulet, Sandrine
    Lejeune, Julien
    Phi-Linh Nguyen Thi-Lambert
    Chastagner, Pascal
    NEURO-ONCOLOGY, 2022, 24 : 106 - 107
  • [8] Neuropsychological Outcome of Children with Medulloblastoma/Ependymoma Younger Than 4 Years: 2 & 5 Year Follow-Up Data from the German HIT2000 & HIT2005Relapse Trials
    Ottensmeier, H.
    Schlegel, P. G.
    Eyrich, M.
    Schmidt, R.
    Faldum, A.
    Mynarek, M.
    Juhnke, B. O.
    Rutkowski, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S450 - S451
  • [9] TREATMENT OF YOUNG CHILDREN (<4 YEARS) WITH MEDULLOBLASTOMA BY CHEMOTHERAPY ALONE. INTERIM RESULTS OF THE PROSPECTIVE MULTICENTER GPOH-TRIAL HIT 2000 (HIT 2000 BIS4) CONFIRMING THE PROGNOSTIC IMPACT OF HISTOLOGY
    von Bueren, A. O.
    Pietsch, T.
    Warmuth-Metz, M.
    Soerensen, N.
    Deinlein, F.
    Schlegel, P. G.
    Kuehl, J.
    Benesch, M.
    Zwiener, I.
    Faldum, A.
    Kortmann, R. D.
    Rutkowski, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II7 - II7
  • [10] European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline
    de Beijer, Ismay A. E.
    Skinner, Roderick
    Haupt, Riccardo
    Grabow, Desiree
    Bardi, Edit
    Beccaria, Andrea
    Nieto, Adela Canete
    Essiaf, Samira
    Filbert, Anna-Liesa
    Gsell, Hannah
    Kienesberger, Anita
    Langer, Thorsten
    Mccolgan, Patricia
    Muraca, Monica
    Rascon, Jelena
    Tallone, Ramona
    Tomasikova, Zuzana
    Uyttebroeck, Anne
    Kremer, Leontien C. M.
    van der Pal, Helena J. H.
    Mulder, Renee L.
    JOURNAL OF CANCER SURVIVORSHIP, 2025, 19 (02) : 603 - 613
1